NCT03775434 - A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 7, 2018

Primary Completion Date

May 18, 2019

Study Completion Date

June 10, 2019

Conditions

EczemaAtopic Dermatitis

Interventions

DRUG

Experimental: B244

B244 suspension in 30ml/bottle

Trial Locations (6)

Virginia Clinical Research, INC, Norfolk

The Indiana Clinical Trials Center, Plainfield

Minnesota Clinical Study Center, Fridley

Skin Specialists, PC, Omaha

Dermatology Trial Associates, Bryant

L.A. Universal Research Center, Inc., Los Angeles